Darlene Noci - Jul 15, 2022 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Development Officer
Signature
/s/ Deborah A. Miller, attorney-in-fact
Stock symbol
NUVL
Transactions as of
Jul 15, 2022
Transactions value $
-$67,963
Form type
4
Date filed
7/19/2022, 05:01 PM
Previous filing
Jul 8, 2022
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $4.08K +3.78K $1.08* 3.78K Jul 15, 2022 Direct F1
transaction NUVL Class A Common Stock Sale -$59.9K -3.48K -92.07% $17.21 300 Jul 15, 2022 Direct F1, F2
transaction NUVL Class A Common Stock Sale -$5.45K -300 -100% $18.18 0 Jul 15, 2022 Direct F1, F3
transaction NUVL Class A Common Stock Options Exercise $108 +100 $1.08* 100 Jul 18, 2022 Direct F1
transaction NUVL Class A Common Stock Sale -$1.71K -100 -100% $17.07 0 Jul 18, 2022 Direct F1
transaction NUVL Class A Common Stock Options Exercise $343 +318 $1.08* 318 Jul 19, 2022 Direct F1
transaction NUVL Class A Common Stock Sale -$5.41K -318 -100% $17.02 0 Jul 19, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -3.78K -2.53% $0.00 146K Jul 15, 2022 Class A Common Stock 3.78K $1.08 Direct F1, F5
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -100 -0.07% $0.00 146K Jul 18, 2022 Class A Common Stock 100 $1.08 Direct F1, F5
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -318 -0.22% $0.00 145K Jul 19, 2022 Class A Common Stock 318 $1.08 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 22, 2021.
F2 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.99, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) of this Form 4.
F3 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.03 to $18.33, inclusive.
F4 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.04, inclusive.
F5 The shares underlying this option vest as follows: 25% of the shares vested on January 11, 2022, and the remainder vest over the next three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.